FCOP Beta-Blockers Filter Could Transform River Treatment

Flooding, storm overflows and unseen chemical residues increasingly stem from the same underlying problem: wastewater treatment works designed for the pollution of an earlier era. A recent laboratory advance offers a reason to move from resignation towards practical action.

Why beta-blockers evade treatment

Medicines transform lives, but residues from their use can enter waterways. Beta-blockers, which are used to treat high blood pressure and irregular heart rhythms, can withstand digestion, liver processing and travel through extensive sewer networks. That durability benefits patients, but it also lets these compounds pass through filters intended to remove grit, fats and microbes. Activated carbon can capture many contaminants, yet standard treatment runs still leave trace quantities of beta-blockers behind. They then accumulate in rivers, where fish behaviour can change, algae growth can become unstable and minor impacts build over time.

Water companies can reliably measure solids, nutrients and pathogens. Micropollutants, however, require chemical analysis rather than mechanical monitoring alone. Every pharmaceutical behaves differently in real wastewater, while temperature, pH and organic matter all influence the outcome. As a result, the divide between laboratory chemistry and healthy rivers continues to grow.

A tailored material developed in Seoul

Researchers led by Professor Yuhoon Hwang at Seoul National University of Science and Technology have reported a selective adsorbent designed specifically for beta-blockers. The substance is a fluorinated covalent organic polymer, commonly abbreviated to FCOP. It is a rigid, porous structure whose walls contain deliberately engineered chemistry. These walls connect with medicine molecules at several points, with the aim of delivering rapid, selective capture in a material that is straightforward to produce.

“In tests, the FCOP removed about 70% of atenolol and more than 67% of metoprolol in under one minute.”

This pace is important in treatment works, where water flows continuously. Extended contact times cost more, whereas fast capture can cut tank requirements and energy use. The researchers also identified a notable trend: removal rises sharply after concentrations exceed a particular point.

“The adsorption followed an S-shaped curve, signalling multilayer stacking rather than a single, thin coat on the surface.”

How FCOP works at molecular level

Its performance depends on three characteristics. Firstly, fluorine atoms in the polymer create powerful directional interactions that help secure drug molecules. Secondly, the negatively charged surface attracts the positively charged beta-blockers normally present under typical water conditions. Thirdly, because the material repels water, hydrophobic parts of drug molecules favour its surface rather than the surrounding liquid. Together, these effects speed up capture as further molecules reach the material.

• Fluorine-based sites serve as molecular hooks for the chosen drug targets.
• A negatively charged surface draws in cationic compounds present in many medicines.
• Hydrophobic areas encourage multilayer formation, increasing capacity at higher concentrations.

The outcome is swift removal at low and medium concentrations, alongside additional capacity when levels spike. This would suit treatment works dealing with daytime peaks, hospital discharges or surges diluted by storms.

What FCOP could offer treatment works

According to the team, the polymer can be manufactured without rare catalysts, lowering the obstacles to large-scale production. Engineers could install it in modular cartridges, apply it to membranes or use it in polishing columns after biological treatment. By changing the framework chemistry, the same approach could be adjusted for different pharmaceutical groups. This could provide routes to address antidepressants, hormones and anti-inflammatories that also persist in rivers.

“Built for precision capture, FCOP-style filters add a missing stage between classic treatment and tomorrow’s trace-pollutant standards.”

Why this matters now in Britain

Concern about river quality is intensifying across Britain. Storm overflows dominate headlines, while micropollutants receive less public attention; nevertheless, regulators monitor them and scientists have identified ecological changes associated with chronic exposure. Traditional upgrades focus on phosphorus, ammonia and bacteria. A dedicated end-of-pipe unit for medicines could be a practical addition, improving removal without requiring entire treatment works to be rebuilt.

Hospitals and pharmaceutical centres could deploy compact on-site systems, reducing the incoming load before wastewater reaches municipal networks. Rural works could use portable cartridges designed for lower flows. Initial trials could focus on beta-blocker hotspots identified through monitoring.

Caveats, trials and major questions

Fluorinated materials reasonably prompt questions over their stability and possible by-products. Treatment operators will require leaching assessments, abrasion testing and plans for end-of-life management. The polymer must either be regenerated safely or replaced simply. Disposal through ash or recycling must not create PFAS-type risks. Current evidence concentrates on removal performance rather than lifetime cycling. Pilot facilities should therefore monitor capacity over numerous runs and assess fouling caused by natural organic matter.

Energy and cost assessments are equally significant. A high-capacity adsorbent that works quickly could reduce pumping duration and the physical footprint required. However, real-world viability will depend on its price per kilogram, the number of regeneration cycles available and the chemicals needed for regeneration. Water companies would also need sensors able to detect concentration peaks, allowing polishing stages to switch operating modes effectively.

From beta-blockers to wider clean-up work

The same design principles could be adapted for other persistent pollutants. Hormones have different charges and ring structures, while antibiotics form complexes with metals and organic matter. Bespoke polymers could be engineered around each of these patterns. A flexible set of tools is more useful than one universal filter. Laboratory collections of COFs and COPs already show potential against dyes, pesticides and per-oxygenated compounds. The key challenge is to scale up synthesis, create durable granules and maintain a low pressure drop.

Pollutant class	Typical source	Observed impact	Targeted fix
Beta-blockers	Cardiovascular drugs	Fish behaviour changes; persistence	FCOP adsorption with charged, fluorinated sites
Antidepressants	Mood disorder treatments	Neurological effects in aquatic life	Tuned COPs with cation-exchange domains
Hormonal residues	Contraceptives, therapies	Endocrine disruption and skewed sex ratios	Affinity resins with steroid-binding pockets
Microplastics	Textiles, tyres, packaging	Vectors for toxins and biofilm formation	Fine screens plus coagulation and advanced oxidation

What to monitor next

Three milestones will show whether this can progress from a paper study to installed pipework. The first is pilot testing in mixed wastewater rather than laboratory water alone, to measure speed under real loading conditions. The second is regeneration performance after dozens of cycles, including any reduction in capacity. The third is compatibility with current processes such as ozonation, UV and biologically activated carbon, enabling treatment works to combine methods without unexpected reactions.

Practical actions for water companies

• Identify pharmaceutical hotspots through high-frequency sampling near hospitals and care homes.
• Trial modular adsorbers after tertiary treatment over four seasons to account for changing conditions.
• Establish regeneration procedures that reduce solvent use and monitor any fluorine release.
• Combine targeted adsorbers with bio-based polishing to lower operational costs.

Viewing river health more broadly

Trace chemicals seldom occur in isolation. Nutrients, metals and microplastics interact with pharmaceuticals, altering both toxicity and transport. Beta-blockers may attach to microplastic surfaces and travel downstream with them. Pesticide pulses after rainfall can also overlap with medicine peaks on Mondays. Monitoring that reflects timing and mixtures provides a more accurate picture than isolated samples.

Members of the public can also help lessen these loads. Safe medicine return schemes prevent pills from being flushed away. GP advice on dosing can reduce unused supplies. Everyday steps that limit fibre shedding and tyre dust also reduce the amount of chemical-carrying material entering drains. These measures cannot replace treatment technology upgrades, but together they reduce the pressure on treatment works.

“Precision filtration closes a long-standing gap: it targets what biology misses, without rebuilding whole facilities.”

Key terms in simple language

• Adsorption: molecules adhere to a surface rather than passing through it.
• Sigmoidal uptake: uptake begins slowly, rises sharply and then levels off as sites and layers fill.
• Covalent organic polymer: a rigid network made from organic building blocks joined by strong bonds.
• Hydrophobic effect: molecules that repel water favour surfaces or one another instead of the liquid around them.

This breakthrough from Korea will not resolve river health by itself. It does, however, provide engineers with a rapid, targeted tool for a particularly stubborn class of chemicals. With pilots, robust safeguards and intelligent deployment, it could help shift the balance towards cleaner, safer water.